Navigation Links
The Zacks Analyst Blog Highlights: Eaton, Baxter International, Bio-Rad Laboratories, INSYS Therapeutics and Boston Scientific
Date:10/25/2013

zacks.com/registration/pfp/?ALERT=ZR_LINK&adid=PR_AB&d_alert=rd_final_rank&t=ETN">Free Report) to beat expectations when it reports third quarter 2013 results before the market opens on Oct 25.

The company had missed the earnings consensus in the second quarter by 1.80%.

Why a Likely Positive Surprise?

Our proven model shows that Eaton is likely to beat earnings because it has the right combination of two key ingredients.

Positive Zacks ESP: Expected Surprise Prediction or Earnings ESP, which represents the difference between the Most Accurate estimate and the Zacks Consensus Estimate, is at +2.68%. This is a meaningful and leading indicator of a likely positive earnings surprise for the shares.

Zacks Rank #3 (Hold): Note that stocks with Zacks Ranks of #1, #2 and #3 have a significantly higher chance of beating earnings. The Sell-rated stocks (#4 and #5) should never be considered going into an earnings announcement.  

The combination of Eaton Corporation's Zacks Rank #3 (Hold) and +2.68% ESP makes us confident of an earnings beat this quarter.

What is Driving the Better-than-Expected Earnings?

Eaton's presence in over 175 countries across the globe diversifies any region-specific risk with ample options to make up for any revenue shortfall in any particular region or market.

Consistent investment in Research & Development helps the company to improve the quality of its product offering and improvise new products. This expands the company's operations and customer base.

In addition, solid performance from the acquired assets is helping the company to post better numbers. We expect this trend to continue this quarter.

 

Baxter Intros HEMOSTAT to Europe

 

Baxter International Inc. (NY
'/>"/>

SOURCE Zacks Investment Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. The Zacks Analyst Blog Highlights: SPDR Health Care Select Sector Fund, SPDR S&P 500, SPDRS&P Biotech ETF, PowerShares S&P SmallCap Health Care Portfolio and PowerShares Dynamic Biotechnology & Genome Portfolio
2. Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund
3. S&P Capital IQ to Share Its Views on the Biotech Bull Market During the Next "ETF Analyst Hour"
4. Rising Concerns Over Food Safety Drives Demand for Agricultural and Environmental Diagnostics, According to New Report by Global Industry Analysts, Inc.
5. Technology Developments Drive Growth in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, According to New Report by Global Industry Analysts, Inc.
6. Rising Interest in Molecular Biology Research Drives Demand for qPCR and dPCR Instrumentation, According to a Soon to be Released Report by Global Industry Analysts, Inc.
7. Increasing Need for Supply of High-Quality Water Drives Growth in the Water Analysis Instrumentation Market, According to New Report by Global Industry Analysts, Inc.
8. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
9. Legislative Benefits and Unmet Needs to Drive the Market for Orphan Drugs, According to a New Report by Global Industry Analysts, Inc.
10. Rising Incidence of Stroke Drives the Global Intracranial Stents Market, According to New Report by Global Industry Analysts, Inc.
11. Global H1N1 Vaccines Market to Reach US $273 Million by 2018, According to a New Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 EquitiesIQ, a ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical company ... the wound care market. , Free report download: ... with a seasoned management team and Board, which launched ...
(Date:1/14/2014)... MA (PRWEB) January 14, 2014 iLab Solutions, ... Detwiler as the new Director of Product Strategy. In this ... well as iLab sub-teams to guide in the development of ... iLab provides the maximum possible benefit to the scientific community ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Class Group of AdvisorsSAN DIEGO, April 20 Trius ... Advisory Board, naming Donald H. Batts, MD, FACP, FIDSA, ... seventh members of the group of anti-infective thought leaders. ... Michigan State University and the Chief of ...
... at 100th Annual Meeting of the American Association for ... from Dendreon Corporation (Nasdaq: DNDN ) presented ... Cancer Treatment) or P-11 Phase 3 study suggesting that ... durable and can be maintained following boosting. The results ...
... have discovered a way to use an ancient life form ... in systems that may be surprisingly simple to build compared ... These tiny, single-celled marine life forms have existed for at ... of the life in the oceans, but they also have ...
Cached Biology Technology:Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board 2Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 2Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 3Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 4Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 5Ancient diatoms lead to new technology for solar energy 2
(Date:4/18/2014)... Seeds that sprout as soon as they,re planted may be ... be more careful. In the wild, a plant whose seeds ... risk disaster. More than just an insurance policy against late ... dormancy has long-term advantages too: Plants whose seeds put ... more species, finds in a team of researchers working at ...
(Date:4/17/2014)... under clinical trials to treat tuberculosis could be the ... against various bacteria, fungal infections and parasites, yet evade ... chemists and collaborators. , Led by U. of I. ... ways the drug SQ109 attacks the tuberculosis bacterium, how ... from yeast to malaria and how targeting multiple ...
(Date:4/17/2014)... Foundation has been named awardee of a three-year ... Defense Spinal Cord Injury Research Program. Gail Forrest, ... double-blinded, controlled, multi-site clinical trial, which will test ... spinal cord injury. Dr. Forrest is assistant director ... Foundation. Two additional sites will participate - the ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2Multitarget TB drug could treat other diseases, evade resistance 2Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
... deafness. , As a leader in stem cell-based research on the ... got a step-by-step plan for making this dream a reality. ... anyone can do it, he's the guy to place your ... this?'" said Heller, PhD, associate professor of otolaryngology, whose accent ...
... all remember a time when we were paralyzed in the ... world, making the right choice can mean the difference between ... choose the thing that leads to a "reward," such as ... and understanding those changes has been the focus of Natural ...
... Your bird field guide may be out of date now ... frogmouth bird on a South Pacific island. , New ... per year is announced globally. David Steadman and Andrew Kratter, ... the surprising new discovery on a collecting expedition in the ...
Cached Biology News:Stem cell transplants explored at Stanford as a possible treatment for hearing loss 2Stem cell transplants explored at Stanford as a possible treatment for hearing loss 3Rewarding fat rats 2UF scientists discover new genus of frogmouth bird in Solomon Islands 2UF scientists discover new genus of frogmouth bird in Solomon Islands 3
... high throughput, water bath thermal cycler capable of ... This equates to 9,216 reactions per run when ... rapidly transfers a basket of plates between three ... are considerably faster than those of peltier block ...
Proliferin (C-14)...
... Dideoxycytidine is a cytidine analog that has been ... Immunogen: Chemical / Small Molecule ... specificity of the ddC antiserum was determined by ... to moles of ddC analog at the 50% ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
Biology Products: